The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: The aim of this study was to examine the expression of CD10 and CD15 in tumor cells, stromal cells and infiltrating inflammatory cells during colorectal carcinoma (CRC) development and to investigate their expression levels between the tumor center and invasive front and compare them to clinicopathological parameters in invasive CRC. Methods: We performed immunohistochemical staining for CD10, CD15, and E-cadherin in 42 cases of CRC, 49 of tubular adenoma, 15 of hyperplastic polyp, and 17 of non-neoplastic colon. Results: CD10 was expressed in tumor cells (tCD10), stromal cells (sCD10) and infiltrating inflammatory cells (iCD10), and CD15 was expressed in tumor cells (tCD15) and infiltrating inflammatory cells (iCD15). Their expressions were progressively increased during CRC development and the iCD10 expression level was significantly correlated with the iCD15 expression level in invasive CRC. Invasive front revealed a higher expression level of iCD10 and iCD15 than the tumor center. Moreover, the iCD15 expression level of invasive front was significantly correlated with the degree of tumor budding and tCD15 in whole tissue sections was closely associated with tumor depth. Conclusions: The present study suggests that the expression of CD10 and CD15 is associated with the development and progression of CRC.
Abstract
Background: The aim of this study was to examine the expression of CD10 and CD15 in tumor cells, stromal cells and infiltrating inflammatory cells during colorectal carcinoma (CRC) development and to investigate their expression levels between the tumor center and invasive front and compare them to clinicopathological parameters in invasive CRC. Methods: We performed immunohistochemical staining for CD10, CD15, and E-cadherin in 42 cases of CRC, 49 of tubular adenoma, 15 of hyperplastic polyp, and 17 of non-neoplastic colon. Results: CD10 was expressed in tumor cells (tCD10), stromal cells (sCD10) and infiltrating inflammatory cells (iCD10), and CD15 was expressed in tumor cells (tCD15) and infiltrating inflammatory cells (iCD15). Their expressions were progressively increased during CRC development and the iCD10 expression level was significantly correlated with the iCD15 expression level in invasive CRC. Invasive front revealed a higher expression level of iCD10 and iCD15 than the tumor center. Moreover, the iCD15 expression level of invasive front was significantly correlated with the degree of tumor budding and tCD15 in whole tissue sections was closely associated with tumor depth. Conclusions: The present study suggests that the expression of CD10 and CD15 is associated with the development and progression of CRC.
참고문헌 (28)
- Sternlicht MD, "How matrix metalloproteinases regulate cell behavior", Annu Rev Cell Dev Biol, 17, pp.463~516 (2001)
- Maguer-Satta V, "Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer", Stem Cells, 29, pp.389~396 (2011)
- Erhuma M, "Expression of neutral endopeptidase (NEP", CD10) on pancreatic tumor cell lines, pancreatitis and pancreatic tumor tissues, 2007, pp.120, 2393~2400
- Ganju RK, "CD10", NEP in non-small cell lung carcinomas. Relationship to cellular proliferation, 1994, pp.94, 1784~1791
- Seiler R, "High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients", Hum Pathol, 43, pp.269~275 (2012)
- Xie L, "CD10-bearing fibroblast inhibits matrigel invasive potency of interleukin-1alpha-producing squamous cell carcinoma by diminishing substance P levels in the tumor microenvironment", Cancer Sci, 101, pp.2570~2578 (2010)
- Fujimoto Y, "CD10 expression in colorectal carcinoma correlates with liver metastasis", Dis Colon Rectum, 48, pp.1883~1889 (2005)
- Fujita S, "Multi-institutional study of risk factors of liver metastasis from colorectal cancer: correlation with CD10 expression", Int J Colorectal Dis, 25, pp.681~686 (2010)
- Ogawa H, "Expression of CD10 by stromal cells during colorectal tumor development", Hum Pathol, 33, pp.806~811 (2002)
- Khanh DT, "Myeloid cells positive for CD10 at invasion front can predict poor outcome in stage II colorectal cancer", Int J Clin Oncol, 17, pp.240~249 (2012)
- Khanh DT, "Prognostic role of CD10(+) myeloid cells in association with tumor budding at the invasion front of colorectal cancer", Cancer Sci, 102, pp.1724~1733 (2011)
- Phillips ML, "ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex", Science, 250, pp.1130~1132 (1990)
- Walz G, "Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells", Science, 250, pp.1132~1135 (1990)
- Matsushita Y, "Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric LeX antigen", Exp Cell Res, 196, pp.20~25 (1991)
- Portela SV, "sLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosis", Histol Histopathol, 26, pp.1305~1316 (2011)
- Doekhie FS, "Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node-negative colorectal cancer patients predict disease recurrence", Cancer Microenviron, 1, pp.141~151 (2008)
- Ueno H, "Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer", Histopathology, 40, pp.127~132 (2002)
- Hamilton SR, "Pathology and genetics of tumours of the digestive system", pp.314~ (2000), IARC Press
- Takahara M, "Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes", J Cutan Pathol, 36, pp.668~674 (2009)
- Cui L, "Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells", PLoS One, 5, pp.e12121~ (2010)
- Dixon MF, "Gastrointestinal epithelial neoplasia: Vienna revisited", Gut, 51, pp.130~131 (2002)
- Connelly JC, "Up-regulation of neutral endopeptidase (CALLA) in human neutrophils by granulocyte-macrophage colony-stimulating factor", J Leukoc Biol, 53, pp.685~690 (1993)
- Demirci U, "Serum granulocyte macrophage-colony stimulating factor: a tumor marker in colorectal carcinoma?", Asian Pac J Cancer Prev, 10, pp.1021~1024 (2009)
- Mantovani A, "Neutrophils in the activation and regulation of innate and adaptive immunity", Nat Rev Immunol, 11, pp.519~531 (2011)
- Ardi VC, "Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis", Proc Natl Acad Sci U S A, 104, pp.20262~20267 (2007)
- Queen MM, "Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression", Cancer Res, 65, pp.8896~8904 (2005)
- Dumitru CA, "Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology", Cancer Immunol Immunother, 61, pp.1155~1167 (2012)
- Nakamori S, "Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study", Cancer Res, 53, pp.3632~3637 (1993)